CompanyPrivateAustin, TX

Ollin Biosciences, Inc

SEC EDGAR ClinicalTrials.gov

10-QAug 11Latest SEC filing, period to Jun 30

Form DJun 24$156M sold

September 2026

Ollin Biosciences registers two Phase 3 trials of OLN324 for diabetic macular edema

Sep 25Weekly roundup, 2 itemsOllin Biosciences, Inc